Guardant Health
GH
$25.36
Share price
-3.35%
Change (1 day)
-12.70%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Market capitalization of Guardant Health (GH)
Market cap: $3.10 Billion
As of May 2024 Guardant Health has a market cap of $3.10 Billion. This makes Guardant Health the world's 3454th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Guardant Health from 2018 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.10 B | -5.48% |
| 2023 | $3.28 B | 17.84% |
| 2022 | $2.78 B | -72.6% |
| 2021 | $10.16 B | -21.09% |
| 2020 | $12.88 B | 75.59% |
| 2019 | $7.33 B | 127.64% |
| 2018 | $3.22 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Guardant Health was reported to be:
$3.10 Billion
$3.10 Billion
$3.10 Billion
$3.10 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $2.93 B | -5.49% | 🇺🇸 USA |
 Natera NTRA | $13.07 B | 321.28% | 🇺🇸 USA |